US FDA audit

October 18, 2010

Bachem is proud to announce the successful completion of a full GMP inspection by the US FDA of its Bubendorf (Switzerland) manufacturing site.

The inspection was conducted by 2 investigators on four inspection days during September 24th – 29th and resulted very successfully with no form FDA 483 or other observations, confirming the high level of GMP compliance of Bachem’s Bubendorf site.